A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Shuzhen Wang et al.|Alzheimer s Research & Therapy|2021Cited by 200
AD7c-NTP Impairs Adult Striatal Neurogenesis by Affecting the Biological Function of MeCP2 in APP/PSl Transgenic Mouse Model of Alzheimer's DiseasePan Li, Yuying Zhou|Frontiers in Aging Neuroscience|2021Cited by 9